Testing a new lithium delivery method for bipolar disorder
Part of Mental health clinical trials.
This study tests a new way to deliver lithium, a common treatment for bipolar disorder, using tiny gold particles. It aims to see if this method is safe and effective in laboratory models, which may lead to better treatments with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with bipolar I or bipolar II disorder.
- You are currently in any mood phase (depressed, manic, mixed, or stable).
- You have not taken psychiatric medications in the last 12 months, except for occasional low-dose sedatives or antipsychotics for sleep or anxiety.
- You have never taken lithium before.
- You are medically stable and can give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how lithium works in everyday life for people with bipolar disorder. It aims to learn about real-world treatment patterns and outcomes.
This trial tests a new medical device that uses a blood test to help doctors accurately diagnose bipolar disorder in people who were thought to have major depression. It aims to see if the device can tell the difference and improve treatment choices.
This trial tests if lithium can help prevent mood episodes from returning in people with bipolar disorder or major depressive disorder. It aims to see if lithium is a safe and effective longer-term treatment.
This study looks at how bipolar disorder (a condition causing swings between extreme highs and lows) changes over time, and how it affects people who are hospitalized. Parcipants will be followed to understand their prognosis, which may help improve care.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This study checks how much lithium is naturally present in the blood and whether that relates to suicidal thoughts or attempts in people with a current major depressive episode. It may help researchers understand biological factors linked to suicide risk and improve future prevention.
Hear when a new Bipolar Disorder (BD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.